Q3 2022 Syros Pharmaceuticals Inc Earnings Call Transcript
Good day, and welcome to the Q3 2022 Syros Pharmaceuticals, Inc. Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. I would now like to turn the conference over to your speaker, Ms. Karen Hunady, Director of Corporate Communications and Investor Relations. Please go ahead.
Thank you. This morning we issued a press release announcing our third quarter 2022 financial results and a broader business update. The release is available on the Investor and Media section of the Syros website at www.syros.com. We will begin the call with prepared remarks by Dr. Nancy Simonian, our Chief Executive Officer; Dr. David Roth, our Chief Medical Officer; and Jason Haas, our Chief Financial Officer. We will then open the call for questions. Kristin Stephens, our Chief Development Officer; Dr. Eric Olson, our Chief Scientific Officer; and Conley Chee, our Chief Commercial Officer, are also on the call and will be available for Q&A.
Before we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
